Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Bioresorbable Polymers industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Polymer type trends
2.4 Application trends
2.5 Regional trends
Chapter 3 Bioresorbable Polymers Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Industry pitfalls & challenges
3.3 Growth potential analysis
3.3.1 By polymer type
3.3.2 By application
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 GAP analysis
3.11 Porter's analysis
3.12 PESTEL analysis
3.13 Impact of Russia Ukraine war
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Bioresorbable Polymers Market Size and Forecast, By Polymer type 2018 - 2032
5.1 Polylactic Acid (PLA)
5.2 Polyglycolic Acid (PGA)
5.3 Polycaprolactone (PCL)
5.4 Polyhydroxyalkanoates (PHA)
5.5 Others
Chapter 6 Bioresorbable Polymers Market Size and Forecast, By Application 2018 - 2032
6.1 Medical Devices
6.2 Pharmaceuticals
6.3 Packaging
6.4 Tissue Engineering
6.5 Agriculture
Chapter 7 Bioresorbable Polymers Market Size and Forecast, By Region 2018 - 2032
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Malaysia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Egypt
Chapter 8 Company Profiles
8.1 Corbion N.V.
8.2 Evonik Industries AG
8.3 Poly-Med, Inc.
8.4 Mitsui Chemicals, Inc.
8.5 Foster Corporation
8.6 KLS Martin Group
8.7 Ashland Global Holdings
8.8 Corbion Purac
8.9 DSM Biomedical
8.10 Mitsubishi Chemical Holdings Corporation
8.11 Bioretec Ltd.
8.12 Solvay S.A.
8.13 KLS Martin LP
8.14 LACTEL Absorbable Polymers (DURECT Corporation)
8.15 Galatea Surgical
